Is your business about to feel the Ozempic squeeze? Opinion Reshaping stomachs with weightloss drugs like Ozempic likely means reshaping some markets (and probably your strategy), says Paul Armstrong Ozempic, Wegovy, and Mounjaro are driving a subtle but undeniable shift in obesity rates across the U.S, showing a 2 per cent drop so far. While it’s too soon to crown these drugs the cure-all, their [...]
Digital health firm explores London listing amid surge in demand for weight-loss jabs Healthcare Digital health business Reset Health is mulling a potential listing on London's stock market as it looks to pounce on the boom in demand for weight-loss jabs.
Ozempic and Wegovy: What happens when a drug goes viral? Wegovy Novo Nordisk's Wegovy and Ozempic have been heralded as the solution to the world's growing obesity problems. But when celebrities and influencers misuse them and start documenting their weight loss journeys online, should we take stock?
The Notebook: Where are retail investors putting their money? May 8, 2024 | City Talk Victoria Scholar takes the Notebook pen to talk retail investors, Ozempic's fat profits, and the UK's inflation forecast.